Phase II trial with navelbine + cisplatin + etoposide in the treatment of inoperable non-small cell lung carcinoma

40 patients with advanced non-small cell lung cancer not previously treated were included in a study at phase II with vinorelbine 20 mg/Sq.m days 1 and 8, etoposide 60 mg/sq.m days 1-3 and cisplatin 75 mg/sq.m day 1 each 28 days for 6 cycles. There were 31 men and 9 women, being the average age of 5...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Richardet, Eduardo Arnoldo, Carranza, L., Uribe, A., Tolocka, H., Cresta, Cecilia, Uribe, E., Uribe, M.
Formato: Artículo
Lenguaje:Español
Publicado: 1995
Materias:
R Medicina (General)
Acceso en línea:http://pa.bibdigital.ucc.edu.ar/3717/1/A_Richardet_Carranza_Uribe_Tolocka_Cresta_Uribe_Uribe.pdf
Aporte de:
Producción Académica Universidad Católica de Córdoba (UCCor) de Universidad Católica de Córdoba

Ejemplares similares

Ejemplares similares